 CAMBRIDGE, Mass., June 4, 2021 PRNewswire -- Blueprint Medicines Corporation NASDAQ: BPMC today announced that, effective on June 1, 2021, the Compensation Committee of Blueprint Medicines Board of Directors granted non-qualified stock options to purchase an aggregate of 49,102 shares of its common stock and an aggregate of 26,793 restricted stock units RSUs to seven new employees, including a grant of non-qualified stock options to purchase 39,200 shares of common stock and 21,843 RSUs to Percy Carter, MBA, Ph.D. 